Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Taysha Gene Therapies Inc’s stock clocked out at $2.16, down -1.82% from its previous closing price of $2.20. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 1.19 million shares were traded. TSHA stock price reached its highest trading level at $2.27 during the session, while it also had its lowest trading level at $2.145.
Ratios:
To gain a deeper understanding of TSHA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Manning Paul B bought 100,000 shares of TSHA for $163,000 on Nov 17 ’23. The 10% Owner now owns 16,566,667 shares after completing the transaction at $1.63 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 448798336 and an Enterprise Value of 328237536. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.40 while its Price-to-Book (P/B) ratio in mrq is 4.00. Its current Enterprise Value per Revenue stands at 25.498 whereas that against EBITDA is -4.335.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.27. The 50-Day Moving Average of the stock is -9.46%, while the 200-Day Moving Average is calculated to be -6.24%.
Shares Statistics:
It appears that TSHA traded 2.55M shares on average per day over the past three months and 1131320 shares per day over the past ten days. A total of 186.96M shares are outstanding, with a floating share count of 157.66M. Insiders hold about 23.07% of the company’s shares, while institutions hold 72.80% stake in the company. Shares short for TSHA as of 1722384000 were 23205915 with a Short Ratio of 9.10, compared to 1719532800 on 13450773. Therefore, it implies a Short% of Shares Outstanding of 23205915 and a Short% of Float of 15.290000000000001.
